Max Robotics — Global Service Robot Directory + US Certification

About

Itsuto Hamano is a leading researcher in geriatric oncology, with a focused expertise on frailty assessment and its impact on prostate cancer treatment outcomes. His work centers on integrating the Geriatric 8 (G8) screening tool into urologic oncology, demonstrating how frailty—not just age—predicts surgical complications, pain, and quality of life after robot-assisted radical prostatectomy. Through landmark studies like the FRART-PC and FRAP studies, Hamano has shown that frail patients face higher risks of moderate-to-severe post-surgical pain and are more likely to be deemed surgically contraindicated, even when their cancer is localized. His prospective evaluations of over 540 patients have collectively garnered more than 100 citations, underscoring the clinical urgency of his findings. Notably, his 2021 analysis of oncologic and patient-reported outcomes in men aged 75 and older challenges conventional age-based treatment thresholds, advocating for personalized, frailty-informed care. Hamano’s work is pivotal for surgeons and oncologists seeking to optimize treatment decisions and improve recovery in older adults with prostate cancer.